Kuros Biosciences

Update in progress

KURN.SW (Swiss)

Company RatingNeutral
SectorHealthcare
IndustryMedical Devices

Kuros Biosciences AG develops and commercializes biologic technologies for musculoskeletal care in the United States, the European Union, and abroad. It operates through Medical Devices and Legacy Portfolio. The company offers MagnetOs Granules, an advanced bone graft with submicron NeedleGrip surface technology; MagnetOs Putty to fill bone voids; and Attrax, biphasic calcium phosphate grafts that mimic cancellous bone. It also handles Checkmate licensing. Founded 2016, headquartered in Schlieren, Switzerland.

Company score

Sentiment: 0.46; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.04; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.28; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.09; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.12; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.29; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive